For enrollment into the HUMIRA treatment group; adult patients with moderately to severely active UC who has been prescribed HUMIRA therapy according to routine clinical practice and meets one of the following:
Is currently taking HUMIRA therapy and has received at least 8 weeks of therapy; OR
Is entering after participation in an Abbott or AbbVie sponsored UC study and; has received continuous HUMIRA therapy since initiation of therapy
For enrollment into the IMM treatment group; adult patients with moderately to severely active UC who has been prescribed IMM therapy, is currently taking IMM therapy, and has received at least 12 consecutive weeks of IMM therapy
Patients capable of and willing to grant authorization for use/disclosure of data being collected and provided to AbbVie prior to any registry-related data being collected, and to comply with the requirements of the Registry protocol
You CAN'T join if...
Patients on IMM therapy without a concurrent biologic if they cannot continue to be treated with IMM therapy or
Patients who are being treated with any investigational agents and/or approved biologics other than Humira.
Moores Cancer Center at UC San Diego /ID# 133722 La Jolla California 92093 United States
Southern California Res. Ctr. /ID# 116898 Coronado California 92118-1408 United States
Precision Research Institute - San Diego /ID# 103638 San Diego California 92114-3643 United States
Precision Research Institute - San Diego /ID# 113445 San Diego California 92114-3643 United States